PATENT CLAIM ANALYSIS

Application Number: 16372958
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-07
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising an NSAID such as meloxicam in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of conditions such as pain.

Claim (Index 24):
The method of  claim 1 , wherein the solid dosage form is orally administered to the human being to treat pain associated with osteoarthritis, rheumatoid arthritis, or juvenile rheumatoid arthritis.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 100.0
- Lexical Diversity: 1.35135
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15936176', '16372977', '16181086', '15989734', '16248449']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8234901139142986
- 35 USC 102 Novelty (BERT): 0.5681894680226467
- Combined Prediction Score: 0.7979600493251334
- Mean Citation Score: 410.306872
- Max Citation Score: 420.07852
- Similarity Product: 394.6815862285567

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test